These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17319747)

  • 1. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk.
    García-Closas M; Malats N; Real FX; Yeager M; Welch R; Silverman D; Kogevinas M; Dosemeci M; Figueroa J; Chatterjee N; Tardón A; Serra C; Carrato A; García-Closas R; Murta-Nascimento C; Rothman N; Chanock SJ
    PLoS Genet; 2007 Feb; 3(2):e29. PubMed ID: 17319747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population.
    Fu D; Li P; Cheng W; Tian F; Xu X; Yi X; Tang C; Wang Y; Hu Q; Zhang Z
    Oncotarget; 2017 Apr; 8(14):22927-22935. PubMed ID: 28206971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
    Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
    J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases.
    Langsenlehner U; Hofmann G; Renner W; Gerger A; Krenn-Pilko S; Thurner EM; Krippl P; Langsenlehner T
    Acta Oncol; 2015 Mar; 54(3):368-76. PubMed ID: 25152223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of glutathione S-transferase μ and θ, MDR1 and VEGF genes as risk factors of bladder cancer: a case-control study.
    Henríquez-Hernández LA; Navarro P; Luzardo OP; Alvarez-León EE; Boada LD; Zumbado M; Pestano J; Suárez JR; Chesa N; Almeida M; Valerón PF
    Urol Oncol; 2012 Sep; 30(5):660-5. PubMed ID: 21292509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
    Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
    Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.
    Figueroa JD; Malats N; Rothman N; Real FX; Silverman D; Kogevinas M; Chanock S; Yeager M; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; García-Closas M
    Carcinogenesis; 2007 Aug; 28(8):1788-93. PubMed ID: 17557904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
    Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
    Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes.
    Enjuanes A; Benavente Y; Hernández-Rodríguez J; Queralt C; Yagüe J; Jares P; de Sanjosé S; Campo E; Cid MC
    Rheumatology (Oxford); 2012 May; 51(5):841-51. PubMed ID: 22258388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility.
    Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR
    Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
    Kiemeney LA; van Houwelingen KP; Bogaerts M; Witjes JA; Swinkels DW; den Heijer M; Franke B; Schalken JA; Verhaegh GW
    Eur J Cancer; 2006 Dec; 42(18):3219-27. PubMed ID: 16934975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
    Hazra A; Chanock S; Giovannucci E; Cox DG; Niu T; Fuchs C; Willett WC; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):311-9. PubMed ID: 18268114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
    Riemann K; Struwe H; Eisenhardt A; Obermaier B; Schmid KW; Siffert W
    Pharmacogenet Genomics; 2008 Nov; 18(11):999-1008. PubMed ID: 18815590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
    Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
    Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
    Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the base excision repair pathway and bladder cancer risk.
    Figueroa JD; Malats N; Real FX; Silverman D; Kogevinas M; Chanock S; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Rothman N; García-Closas M
    Hum Genet; 2007 Apr; 121(2):233-42. PubMed ID: 17203305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERCC1 haplotypes modify bladder cancer risk: a case-control study.
    Ricceri F; Guarrera S; Sacerdote C; Polidoro S; Allione A; Fontana D; Destefanis P; Tizzani A; Casetta G; Cucchiarale G; Vineis P; Matullo G
    DNA Repair (Amst); 2010 Feb; 9(2):191-200. PubMed ID: 20061190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
    Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
    Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype-based association of Vascular Endothelial Growth Factor gene polymorphisms with urothelial bladder cancer risk in Tunisian population.
    Ben Wafi S; Kallel A; Ben Fradj MK; Sallemi A; Ben Rhouma S; Ben Halima M; Sanhaji H; Nouira Y; Jemaa R; Feki M
    J Clin Lab Anal; 2018 Nov; 32(9):e22610. PubMed ID: 29959793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.